Co-Authors
This is a "connection" page, showing publications co-authored by Emily Martin and Arnold Monto.
Connection Strength
3.184
-
The Doctrine of Original Antigenic Sin: Separating Good From Evil. J Infect Dis. 2017 06 15; 215(12):1782-1788.
Score: 0.721
-
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses. J Infect Dis. 2021 07 02; 224(1):49-59.
Score: 0.239
-
Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study. Influenza Other Respir Viruses. 2021 03; 15(2):227-234.
Score: 0.227
-
Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan. J Infect Dis. 2020 06 16; 222(1):9-16.
Score: 0.222
-
Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials. Clin Infect Dis. 2018 05 02; 66(10):1492-1500.
Score: 0.191
-
The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review. Vaccine. 2018 01 02; 36(1):141-147.
Score: 0.186
-
The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine. Clin Infect Dis. 2017 Oct 30; 65(10):1644-1651.
Score: 0.185
-
Respiratory syncytial virus hospitalization in middle-aged and older adults. J Clin Virol. 2017 Nov; 96:37-43.
Score: 0.183
-
Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators. Clin Infect Dis. 2021 12 16; 73(12):2240-2247.
Score: 0.062
-
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 27; 70(34):1156-1162.
Score: 0.060
-
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. Clin Infect Dis. 2021 Aug 06.
Score: 0.060
-
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged =65 Years - United States, January-March 2021. MMWR Morb Mortal Wkly Rep. 2021 May 07; 70(18):674-679.
Score: 0.059
-
Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa576.
Score: 0.057
-
Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel: 2015-2016, 2016-2017, and 2017-2018. Clin Infect Dis. 2019 11 27; 69(12):2153-2161.
Score: 0.053
-
Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). J Infect Dis. 2019 09 13; 220(8):1265-1275.
Score: 0.053
-
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy. BMC Infect Dis. 2019 May 22; 19(1):453.
Score: 0.052
-
Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness. Vaccine. 2019 06 27; 37(29):3849-3855.
Score: 0.051
-
Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol. BMC Infect Dis. 2018 Nov 06; 18(1):550.
Score: 0.050
-
Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo. J Virol. 2018 10 01; 92(19).
Score: 0.049
-
Human coronaviruses and other respiratory infections in young adults on a university campus: Prevalence, symptoms, and shedding. Influenza Other Respir Viruses. 2018 09; 12(5):582-590.
Score: 0.049
-
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. J Infect Dis. 2018 06 20; 218(2):189-196.
Score: 0.048
-
Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain. Vaccine. 2018 06 27; 36(28):4095-4101.
Score: 0.048
-
Stochastic processes constrain the within and between host evolution of influenza virus. Elife. 2018 05 03; 7.
Score: 0.048
-
Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons-United States, 2011-2016. Clin Infect Dis. 2018 03 19; 66(7):1035-1041.
Score: 0.047
-
Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. Vaccine. 2018 02 28; 36(10):1272-1278.
Score: 0.047
-
Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. MMWR Morb Mortal Wkly Rep. 2018 Feb 16; 67(6):180-185.
Score: 0.047
-
Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States. J Infect Dis. 2017 07 15; 216(2):284-285.
Score: 0.045
-
Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. MMWR Morb Mortal Wkly Rep. 2017 Feb 17; 66(6):167-171.
Score: 0.044